Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Noked Israel Ltd

Q2 2024 · 13F-HR

Noked Israel Ltdholdings as filed

Filed 2024-08-14 · accession 0001178913-24-002582

$362,366
Reported value
15
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
874039100TSMTAIWAN SEMICONDUCTOR MFG LTD$68,70719.0%395,300CommonSOLE
594918104MSFTMICROSOFT CORP$61,67917.0%138,000CommonSOLE
02079K107GOOGALPHABET INC$44,05712.2%240,200CommonSOLE
023135106AMZNAMAZON COM INC$40,42811.2%209,200CommonSOLE
M98068105WIXWIX COM LTD$30,7018.47%193,000CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$27,3817.56%1,685,000CommonSOLE
30303M102METAMETA PLATFORMS INC$27,3547.55%54,250CommonSOLE
09857L108BKNGBOOKING HOLDINGS INC$20,6005.68%5,200CommonSOLE
45841N107IBKRINTERACTIVE BROKERS GROUP IN$14,0993.89%115,000CommonSOLE
037833100AAPLAPPLE INC$12,6793.50%60,200CommonSOLE
79466L302CRMSALESFORCE INC$7,7132.13%30,000CommonSOLE
46090E103QQQINVESCO QQQ TR$3,3250.92%6,940CommonSOLE
78462F103SPYSPDR S&P 500 ETF TR$2,6090.72%4,794CommonSOLE
M98068905WIX COM LTD$5510.15%130CommonSOLE
98386D307XTL BIOPHARMACEUTICALS LTD$4830.13%198,888CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.